Yanqun Z. Wang
Guangzhou International Bio Island
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 96 publications
Nanobodies targeting SARS-CoV-2 papain-like protease exert dual antiviral and anti-inflammatory effects.
Journal: Journal of virology
Published: August 28, 2026
Corrigendum to "Integrated multiplex PCR and metatranscriptomics reveal upper-lower airway microbial landscapes in pediatric respiratory infections" [Virol. Sin. 41 (2026) 58-69].
Journal: Virologica Sinica
Published: June 11, 2026
Identification and characterization of anti-chikungunya virus compounds using a biosafe toolkit.
Journal: Virologica Sinica
Published: April 30, 2026
Isolation and genomic characterization of Chikungunya virus during the 2025 outbreak in Foshan, China.
Journal: Emerging microbes & infections
Published: November 26, 2025
Immune profiling of mpox survivors reveals divergent durability of antibody and T cell responses.
Journal: Nature communications
Published: September 12, 2025
Integrated multiplex PCR and metatranscriptomics reveal upper-lower airway microbial landscapes in pediatric respiratory infections.
Journal: Virologica Sinica
Published: August 26, 2025
Nanoparticle vaccine based on the pre-fusion F glycoprotein of respiratory syncytial virus elicits robust protective immune responses.
Journal: Journal of virology
Published: August 26, 2025
Precision-engineered STING agonist nanoparticles enable coordinated mucosal-systemic immunity for durable pan-β-coronavirus protection.
Journal: Nature nanotechnology
Published: August 05, 2025
Unveiling the epitope repertoires and protective roles of MERS-CoV-specific T cells in mice.
Journal: Cell reports
Published: July 21, 2025
Cross-clade vaccination to overcome sarbecovirus or merbecovirus neutralization gaps.
Journal: Cell reports
Published: July 06, 2025
Development of broadly neutralizing antibodies against Omicron variants from existing neutralizing antibodies in clinical trials.
Journal: Virology journal
Published: March 26, 2025
Corrigendum to "IgA class switching enhances neutralizing potency against SARS-CoV-2 by increased antibody hinge flexibility" [Antiv. Res. (2025) 106082].
Journal: Antiviral research
Published: March 21, 2025
Last Updated: 09/26/2026